HDAC9 and cancer: Of this first generation compounds, SAHA (Vorinostat), PXD101 (Belinostat), Romidepsin (Istodax), and RAS2410 (Resminostat) have received approval for the treatment of various cancers and were thought to target several or most members of the HDAC family.